Health

Results: 7537-7548 of 9384

Hansa Biopharma Expects Strong First Quarter 2024 Sales Performance

GlobeNewswire associated0

ONWARD® Medical Submits De Novo Application to FDA for its ARC-EX® System

Protembis Announces First Patient Enrolled in the PROTEMBO IDE Pivotal Trial

MindMed Announces Voluntary Delisting from Cboe Canada

Inner hair cells in the inner ear (picture: Nemes Laszlo/Shutterstock.com)

Sudden Hearing Loss: AudioCure's Novel Compound AC102 Restores Hearing in Preclinical Models, Published in PNAS

Oncoclínicas&Co has revenues of R$6 billion and profit of R$313 million in 2023

PR Newswire associated0

Endo, Inc. Announces Proposed New Senior Secured Credit Facilities

Alzheimer's Drug Discovery Foundation and Harrington Discovery Institute Center for Brain Health Medicines Invite Proposals for 2024 ADDF-Harrington Scholar Award

ThinkCyte advances biopharma phenotypic drug discovery programs with publication and presentation milestones

PR Newswire associated0

Novel Immunogenicity Risk Assessment Platform, ISPRI, Facilitates Biologic Therapeutics Development

Vertex Advances Inaxaplin (VX-147) into Phase 3 Portion of Adaptive Phase 2/3 Clinical Trial for the Treatment of APOL1-Mediated Kidney Disease

Peter Carbone, KBI Biopharma Chief Quality Officer (Photo: Business Wire)

KBI Biopharma Strengthens Quality and Regulatory Affairs Expertise with Appointment of Chief Quality Officer